Research Methods Core: Cognitive Neuroscience

研究方法核心:认知神经科学

基本信息

项目摘要

The revolutionary growth of the cognitive neurosciences offers enormous promise for understanding the mechanisms underlying antipsychotic interventions. The overarching goal of the Research Methods Core is to support the application of state-of-the-art neurocognitive and neuroimaging methodologies that may help clarify the mechanisms underlying effective intervention in schizophrenia such as the prediction of treatment response, functional outcome, and adverse events in a unique cohort of first episode patients with minimal or no prior antipsychotic drug exposure. Compared to conventional treatment targets such as clinical symptomatology, cognitive neuroscience methods theoretically are more closely representative of brain dysfunction, and should ultimately be superior: (1) in classifying individuals who will benefit differentially from specific treatments, and some day, in the selection, dosing and titration of treatments; (2) in identifying the stable, enduring features of pathology that are most likely to predict distinctive outcomes, with implications for disposition and rehabilitative efforts; (3) in identifying neurobiological mechanisms that mediate treatment response with current, second-generation antipsychotics; and finally, (4) in serving as treatment targets themselves, possibly leading to the next generation of rationally-derived treatments. Moreover, information derived from cognitive neuroscience methods in well-controlled clinical trials will further provide crucial feedback to basic neuroscience research about the mechanisms underlying effective treatment. The Research Methods Core provides infrastructure support for the individual research projects, which include assessment of neurocognitive functioning, region-of-interest volumetric approaches, diffusion tensor imaging, cortical surface mapping and positron emission tomography to predict treatment response and multidimensional outcome measures. The specific aims of the Core include: (1) to integrate individual projects within the Center; (2) to develop innovative methods for data analysis and image processing; (3) to communicate findings and train investigators in neuropsychological and neuroimaging methods and (4) to maintain high standards of reliability for individual research projects. Mechanisms by which the Core accomplishes these aims will be addressed in turn, after a brief overview of the three major platforms for cognitive neuroscience research within the ZHH CIDAR.
认知神经科学的革命性发展为理解神经系统的功能提供了巨大的希望。 抗精神病药物干预的潜在机制。研究方法核心的总体目标是 支持最先进的神经认知和神经成像方法的应用, 阐明精神分裂症有效干预的机制,如治疗的预测 在一个独特的首次发作患者队列中, 没有服用过抗精神病药物与常规治疗目标相比, 认知神经科学的方法在理论上更能代表脑科学 功能障碍,并应最终是上级:(1)在分类的个人谁将受益于差异 具体的治疗,并有一天,在选择,剂量和滴定的治疗;(2)在确定 稳定的,持久的病理学特征,最有可能预测独特的结果, 用于处置和康复努力;(3)识别介导治疗的神经生物学机制 与当前的第二代抗精神病药的反应;最后,(4)作为治疗目标 可能导致下一代合理衍生的治疗方法。此外,信息 来自认知神经科学方法的良好对照临床试验将进一步提供关键的 反馈到基础神经科学研究中关于有效治疗的机制。的 研究方法核心为个别研究项目提供基础设施支持,包括 神经认知功能评估,感兴趣区容积法,弥散张量 成像、皮质表面映射和正电子发射断层扫描,以预测治疗反应, 多维度结果测量。核心的具体目标包括:(1)整合个人 (2)开发数据分析和图像处理的创新方法;(3) 交流研究结果,并对研究人员进行神经心理学和神经影像学方法的培训;(4) 保持高标准的可靠性为个别研究项目。核心小组通过何种机制 实现这些目标将依次讨论,在简要概述了三个主要平台, ZHH CIDAR中的认知神经科学研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Terry Goldberg其他文献

Terry Goldberg的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Terry Goldberg', 18)}}的其他基金

Cognitive Assessment and Adjudication Core
认知评估与判定核心
  • 批准号:
    10507631
  • 财政年份:
    2022
  • 资助金额:
    $ 26.59万
  • 项目类别:
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials
阿尔茨海默病预防试验的新认知和功能测量
  • 批准号:
    10179171
  • 财政年份:
    2018
  • 资助金额:
    $ 26.59万
  • 项目类别:
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials
阿尔茨海默病预防试验的新认知和功能测量
  • 批准号:
    10202448
  • 财政年份:
    2018
  • 资助金额:
    $ 26.59万
  • 项目类别:
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials
阿尔茨海默病预防试验的新认知和功能测量
  • 批准号:
    10440277
  • 财政年份:
    2018
  • 资助金额:
    $ 26.59万
  • 项目类别:
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials
阿尔茨海默病预防试验的新认知和功能测量
  • 批准号:
    9763392
  • 财政年份:
    2018
  • 资助金额:
    $ 26.59万
  • 项目类别:
BDNF val66met Genotype and Age: Hurricane Sandy Supplement
BDNF val66met 基因型和年龄:飓风桑迪补充剂
  • 批准号:
    8744534
  • 财政年份:
    2013
  • 资助金额:
    $ 26.59万
  • 项目类别:
BDNF val66met Genotype and Age: Impact on Biomarkers and Exercise-based Treatment
BDNF val66met 基因型和年龄:对生物标志物和运动治疗的影响
  • 批准号:
    8523730
  • 财政年份:
    2011
  • 资助金额:
    $ 26.59万
  • 项目类别:
BDNF val66met Genotype and Age: Impact on Biomarkers and Exercise-based Treatment
BDNF val66met 基因型和年龄:对生物标志物和运动治疗的影响
  • 批准号:
    8852512
  • 财政年份:
    2011
  • 资助金额:
    $ 26.59万
  • 项目类别:
BDNF val66met Genotype and Age: Impact on Biomarkers and Exercise-based Treatment
BDNF val66met 基因型和年龄:对生物标志物和运动治疗的影响
  • 批准号:
    8187331
  • 财政年份:
    2011
  • 资助金额:
    $ 26.59万
  • 项目类别:
BDNF val66met Genotype and Age: Impact on Biomarkers and Exercise-based Treatment
BDNF val66met 基因型和年龄:对生物标志物和运动治疗的影响
  • 批准号:
    8726265
  • 财政年份:
    2011
  • 资助金额:
    $ 26.59万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 26.59万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 26.59万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 26.59万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 26.59万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 26.59万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 26.59万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 26.59万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 26.59万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 26.59万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 26.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了